Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 334,177 | 13,291 | 39,133 | 24,300 | 12,972 |
| Depreciation Amortization | 22,192 | 10,921 | 42,651 | 30,161 | 19,122 |
| Income taxes - deferred | N/A | N/A | 275 | N/A | N/A |
| Other Working Capital | -47,499 | -20,155 | -54,157 | -51,076 | 8,770 |
| Loans | -5,228 | -13,297 | -44,176 | -53,601 | 15,725 |
| Other Operating Activity | -269,706 | 15,319 | 100,346 | 95,677 | 11,683 |
| Operating Cash Flow | $33,936 | $6,079 | $84,072 | $45,461 | $68,272 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,647 | -1,814 | -15,881 | -13,069 | -9,595 |
| Net Acquisitions | 121,098 | 121,098 | N/A | N/A | N/A |
| Purchase Of Investment | -74,566 | -74,562 | -770,876 | -274,013 | -244,841 |
| Sale Of Investment | 694,790 | 350,280 | 1,122,203 | 726,736 | 613,935 |
| Net Loans | -223,142 | -123,455 | -194,280 | -214,758 | -137,405 |
| Other Investing Activity | 32,834 | 4,661 | 237,235 | 188,657 | 150,754 |
| Investing Cash Flow | $546,367 | $276,208 | $378,401 | $413,553 | $372,848 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 561 | 10,032 | 23,251 | 23,840 | 26,182 |
| Debt Repayment | -200,104 | -200,052 | -1,519 | -148 | -98 |
| Common Stock Issued | 236 | 319 | N/A | 0 | 0 |
| Other Financing Activity | -50,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-634,270 | $-421,570 | $-403,457 | $-408,075 | $-280,925 |
| Beginning Cash Position | 470,599 | 470,599 | 411,583 | 411,583 | 411,583 |
| End Cash Position | 416,632 | 331,316 | 470,599 | 462,522 | 571,778 |
| Net Cash Flow | $-53,967 | $-139,283 | $59,016 | $50,939 | $160,195 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,936 | 6,079 | 84,072 | 45,461 | 68,272 |
| Capital Expenditure | -4,647 | -1,814 | N/A | -13,069 | -9,595 |
| Free Cash Flow | 29,289 | 4,265 | 84,072 | 32,392 | 58,677 |